- Home
- SKYT vs TNGX Comparison
SKYT vs TNGX Comparison
Compare SKYT & TNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SKYT
- TNGX
- Stock Information
- Founded
- SKYT 1991
- TNGX 2014
- Country
- SKYT United States
- TNGX United States
- Employees
- SKYT N/A
- TNGX N/A
- Industry
- SKYT Semiconductors
- TNGX Biotechnology: Pharmaceutical Preparations
- Sector
- SKYT Technology
- TNGX Health Care
- Exchange
- SKYT Nasdaq
- TNGX Nasdaq
- Market Cap
- SKYT 339.1M
- TNGX 317.4M
- IPO Year
- SKYT 2021
- TNGX N/A
- Fundamental
- Price
- SKYT $8.38
- TNGX $1.40
- Analyst Decision
- SKYT Strong Buy
- TNGX Strong Buy
- Analyst Count
- SKYT 3
- TNGX 7
- Target Price
- SKYT $11.67
- TNGX $12.33
- AVG Volume (30 Days)
- SKYT 562.7K
- TNGX 579.6K
- Earning Date
- SKYT 05-07-2025
- TNGX 05-12-2025
- Dividend Yield
- SKYT N/A
- TNGX N/A
- EPS Growth
- SKYT N/A
- TNGX N/A
- EPS
- SKYT N/A
- TNGX N/A
- Revenue
- SKYT $323,929,000.00
- TNGX $40,990,000.00
- Revenue This Year
- SKYT N/A
- TNGX N/A
- Revenue Next Year
- SKYT $22.65
- TNGX N/A
- P/E Ratio
- SKYT N/A
- TNGX N/A
- Revenue Growth
- SKYT 7.90
- TNGX 10.09
- 52 Week Low
- SKYT $5.63
- TNGX $1.11
- 52 Week High
- SKYT $19.00
- TNGX $12.02
- Technical
- Relative Strength Index (RSI)
- SKYT 65.21
- TNGX 50.19
- Support Level
- SKYT $7.02
- TNGX $1.07
- Resistance Level
- SKYT $7.65
- TNGX $1.56
- Average True Range (ATR)
- SKYT 0.49
- TNGX 0.16
- MACD
- SKYT 0.15
- TNGX 0.01
- Stochastic Oscillator
- SKYT 93.80
- TNGX 69.81
About SKYT SkyWater Technology Inc.
SkyWater Technology Inc is a U.S.-based, independent, pure-play technology foundry that offers semiconductor development and manufacturing services from its fabrication facilities. In its technology as a service model, it leverages a foundation of proprietary technology, engineering to co-develop process technology intellectual property (IP) with its customers that enable disruptive concepts through its Technology Services for diverse microelectronics (integrated circuits) and related micro- and nanotechnology applications. It focuses on serving diversified, high-growth, end users in numerous vertical markets, including computation, aerospace and defense (A&D), automotive and transportation, bio-health, and industrial.
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.